Form EFFECT Scinai Immunotherapeutic
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 8, 2025 |
| Accession Number: | 0001213900-25-084488 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acqua Funding Launches New High-Leverage Bridge Financing for Residential Real Estate Investors
- Clarity Narrative Introduces Service to Help Businesses Address the Hidden Cost of AI Misrepresentation
- Jaadugar A Witch in Mongolia Set to Premiere with QUEEN BEE STAR Ending Theme, New PV and Visual
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
